Trial intelligence / Profile preview

Atorvastatin for Vasospastic Angina (ESAVA)

NCT00620204Phase 4Unknown

Sponsor
Samsung Medical Center
Start
Jan 2008
Primary completion
Dec 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of atorvastatin in variant angina, sponsored by Samsung Medical Center. Status: unknown.

02

Drugs

atorvastatin
03

Conditions

variant angina

Beyond the preview

Go deeper on NCT00620204.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00620204.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call